CYTORI THERAPEUTICS, INC. Contracts & Agreements

Form of Series A Warrant (May 2024, as amended and restated August 2024) (Filed With SEC on August 14, 2024)

Form of Series B Warrant (May 2024, as amended and restated August 2024) (Filed With SEC on August 14, 2024)

Form of Amendment and Restatement of the Plus Therapeutics, Inc. Series A Common Stock Purchase Warrant (Filed With SEC on August 14, 2024)

Form of Amendment and Restatement of the Plus Therapeutics, Inc. Series B Common Stock Purchase Warrant (Filed With SEC on August 14, 2024)

Third Amendment to The Plus Therapeutics, Inc. 2015 New Employee Incentive Plan (Filed With SEC on June 7, 2024)

Lending Agreement, dated April 5, 2024, by and between Plus Therapeutics, Inc. and Pershing LLC (Filed With SEC on June 4, 2024)

Loan Interest Rate Form, dated May 24, 2024, by and between Plus Therapeutics, Inc. and Pershing LLC (Filed With SEC on June 4, 2024)

Extension of Credit, dated May 29, 2024, by and between Plus Therapeutics, Inc. and Pershing LLC (Filed With SEC on June 4, 2024)

Form of Pre-Funded Warrant (Filed With SEC on May 9, 2024)

Form of Series A Warrant (Filed With SEC on May 9, 2024)

Form of Series B Warrant (Filed With SEC on May 9, 2024)

Securities Purchase Agreement, dated as of May 5, 2024, by and among Plus Therapeutics, Inc. and the purchasers named therein (Filed With SEC on May 9, 2024)

First Amendment to Securities Purchase Agreement, dated as of May 8, 2024, by and among Plus Therapeutics, Inc. and the purchasers named therein (Filed With SEC on May 9, 2024)

Registration Rights Agreement, dated as of May 5, 2024, by and among Plus Therapeutics, Inc. and the purchasers named therein (Filed With SEC on May 9, 2024)

Ten Amendment to Loan and Security Agreement, dated June 28, 2023, by and among Plus Therapeutics, Inc., Oxford Finance, LLC and lenders listed thereof (Filed With SEC on March 5, 2024)

Tenth Amendment to Loan and Security Agreement (Filed With SEC on August 14, 2023)

Subscription and Investment Representation Agreement, dated March 3, 2023, by and between Plus Therapeutics, Inc. and the purchaser signatory thereto (Filed With SEC on March 3, 2023)

Cancer Research Grant Contract, effective August 31, 2022, by and between the Cancer Prevention and Research Institute of Texas and Plus Therapeutics, Inc (Filed With SEC on September 22, 2022)

Distribution Agreement, dated September 9, 2022, by and among Plus Therapeutics, Inc. and Canaccord Genuity LLC (Filed With SEC on September 9, 2022)

Purchase Agreement, dated August 2, 2022, by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 8, 2022)

Registration Rights Agreement, dated August 2, 2022, by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 8, 2022)

Plus Therapeutics, Inc. 2020 Stock Incentive Plan, as further amended and restated (Filed With SEC on May 20, 2022)

Medidata Services Agreement and Statement of Work (Filed With SEC on April 21, 2022)

Patent & Technology License Agreement, dated December 31, 2021, between Plus Therapeutics, Inc. and the University of Texas Health Science Center at San Antonio (Filed With SEC on February 24, 2022)

Form of Notice of Grant and Stock Option Agreement under the 2020 Stock Incentive Plan (Filed With SEC on February 24, 2022)

Distribution Agreement, dated January 14, 2022, by and among Plus Therapeutics, Inc. and Canaccord Genuity LLC (Filed With SEC on January 14, 2022)

LaFrance Employment Agreement, dated September 7, 2021 (Filed With SEC on September 13, 2021)

Plus Therapeutics, Inc., 2020 Stock Incentive Plan, as amended and restated (Filed With SEC on May 20, 2021)

Master Services Agreement between Piramal Pharma Solutions, Inc. and Plus Therapeutics, Inc (Filed With SEC on February 22, 2021)

Distribution Agreement, dated October 23, 2020, by and among Plus Therapeutics, Inc. and Canaccord Genuity LLC (Filed With SEC on October 23, 2020)

Purchase Agreement, dated September 30, 2020 by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 6, 2020)

Registration Rights Agreement, dated September 30, 2020 by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on October 6, 2020)

Form of Underwriter Warrant Amendment Agreement (Filed With SEC on October 5, 2020)

Plus Therapeutics, Inc., 2020 Equity Incentive Plan (Filed With SEC on June 17, 2020)

Amended and Restated Employment Agreement between Marc Hedrick and Plus Therapeutics, Inc (Filed With SEC on May 14, 2020)

Amended and Restated Employment Agreement between Andrew Sims and Plus Therapeutics, Inc (Filed With SEC on May 14, 2020)

Form of Warrant Amendment Agreement (Filed With SEC on April 23, 2020)

Description of Securities (Filed With SEC on March 30, 2020)

Second Amendment to the Plus Therapeutics, Inc. 2015 New Employee Incentive Plan, dated February 6, 2020 (Filed With SEC on March 30, 2020)

Patent and Know-How License Agreement, dated March 29, 2020, between Plus Therapeutics, Inc. and NanoTx, Corp (Filed With SEC on March 30, 2020)

Ninth Amendment to the Loan and Security Agreement, dated March 29, 2020, between Plus Therapeutics, Inc. and Oxford Finance LLC (Filed With SEC on March 30, 2020)

Employment Agreement between Plus Therapeutics, Inc. and Marc Hedrick (Filed With SEC on March 12, 2020)

Employment Agreement between Plus Therapeutics, Inc. and Andrew Sims (Filed With SEC on March 12, 2020)

Form of Indemnification Agreement (Filed With SEC on February 6, 2020)

Form of Underwriting Agreement (Filed With SEC on September 16, 2019)

Form of Series U Warrant (Filed With SEC on September 16, 2019)

Form of Series V Warrant (Filed With SEC on September 16, 2019)

Seventh Amendment to Loan and Security Agreement, effective as of April 24, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 15, 2019)

Eighth Amendment to Loan and Security Agreement, effective as of July 15, 2019, by and between Plus Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 15, 2019)

2014 Equity Incentive Plan of Plus Therapeutics, Inc., as Amended and Restated (Filed With SEC on August 15, 2019)

Seventh Amendment to Loan and Security Agreement, effective as of April 24, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on May 14, 2019)

Asset and Share Sale and Purchase Agreement, dated as of April 19, 2019, by and between Cytori Therapeutics, Inc. and Seijir Shirahama (Filed With SEC on April 23, 2019)

Fifth Amendment to Loan and Security Agreement dated February 13, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on March 29, 2019)

Sixth Amendment to Loan and Security Agreement dated March 4, 2019, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on March 29, 2019)

Fourth Amendment to Loan and Security Agreement dated December 31, 2018, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on February 1, 2019)

Third Amendment to Loan and Security Agreement, dated August 31, 2018, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on September 21, 2018)

Second Amendment to Loan and Security Agreement, dated June 19, 2018, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 14, 2018)

Amendment to Dealer-Manager Agreement, dated as of July 24, 2018, by and between Cytori Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on July 25, 2018)

Sales Agreement, dated June 1, 2018, by and between Cytori Therapeutics, Inc. and B. Riley FBR, Inc (Filed With SEC on June 1, 2018)

Form of Common Stock Certificate (Filed With SEC on March 9, 2018)

First Amendment to Lease Agreement, dated July 27, 2017, by and between 6262 Lusk Investors LLC and Cytori Therapeutics, Inc (Filed With SEC on March 9, 2018)

Second Amendment to Lease Agreement, dated September 7, 2017, by and between 6262 Lusk Investors LLC and Cytori Therapeutics, Inc (Filed With SEC on March 9, 2018)

Lease Termination Agreement, dated February 21, 2018, by and between 6262 Lusk Investors LLC and Cytori Therapeutics, Inc (Filed With SEC on February 23, 2018)

RESTATED WARRANT AGENT AGREEMENT (Filed With SEC on August 11, 2017)

CERTAIN MATERIAL (INDICATED BY ASTERISKS) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH... (Filed With SEC on August 11, 2017)

CYTORI THERAPEUTICS, INC. UNDERWRITING AGREEMENT (Filed With SEC on April 12, 2017)

COMMON STOCKPURCHASE WARRANT CYTORI THERAPEUTICS, INC. (Filed With SEC on April 12, 2017)

PAGE OF PAGES (Filed With SEC on March 24, 2017)

THIRD AMENDMENT TO THE 2014 EQUITY INCENTIVE PLAN OF CYTORI THERAPEUTICS, INC. (Filed With SEC on March 24, 2017)

ASSET PURCHASE AGREEMENT by and between Cytori Therapeutics, Inc. and Azaya Therapeutics, Inc. January 16, 2017 TABLE OF CONTENTS (Filed With SEC on March 24, 2017)

LEASE AGREEMENT BETWEEN 6262 LUSK INVESTORS LLC, a California limited liability company (LANDLORD) AND CYTORI THERAPEUTICS, INC., a Delaware corporation (TENANT) February 27, 2017... (Filed With SEC on March 24, 2017)

FIRST AMENDMENT TO THE Cytori Therapeutics, INC. 2015 New EMPLOYEe INcentive Plan (Filed With SEC on March 24, 2017)

PURCHASE AGREEMENT (Filed With SEC on December 29, 2016)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on December 29, 2016)

PAGE OF PAGES (Filed With SEC on November 9, 2016)

PAGE OF PAGES (Filed With SEC on August 5, 2016)

CYTORI THERAPEUTICS, INC. (Filed With SEC on June 13, 2016)

FORM OF CYTORI THERAPEUTICS, INC. DEALER-MANAGER AGREEMENT , 2016 (Filed With SEC on May 11, 2016)

FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on May 11, 2016)

[Form of Warrant Certificate] [FACE] (Filed With SEC on May 11, 2016)

WARRANT AGENT AGREEMENT (Filed With SEC on May 11, 2016)

Amendment Two to Joint Venture Termination Agreement, dated January 8, 2016, by and between the Company and Olympus Corporation (filed with this Form 10-Q) (Filed With SEC on May 10, 2016)

FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on April 6, 2016)

Amendment to Common Stock Purchase Warrant (Filed With SEC on March 11, 2016)

Amendment to Series A-1 Warrant to Purchase Common Stock (Filed With SEC on March 11, 2016)

Amendment to Series A-2 Warrant to Purchase Common Stock (Filed With SEC on March 11, 2016)

Amendment One to the Securities Purchase Agreement between the Company and certain institutional investors dated May 5, 2015 (Filed With SEC on March 11, 2016)

Form of Agreement for Acceleration and/or Severance (Filed With SEC on March 11, 2016)

CYTORI THERAPEUTICS, INC. 2015 NEW EMPLOYEE INCENTIVE PLAN CYTORI THERAPEUTICS, INC. 2015 New Employee Incentive Plan (Filed With SEC on January 5, 2016)

Loan and Security Agreement, dated May 29, 2015, by and between Cytori Therapeutics, Inc. and Oxford Finance, LLC (Filed With SEC on August 10, 2015)

Amendment One to the Securities Purchase Agreement, dated March 16, 2015, between the Company and certain institutional investors (Filed With SEC on May 11, 2015)

[FORM OF SERIES A-1 WARRANT] (Filed With SEC on May 5, 2015)

[FORM OF SERIES A-2 WARRANT] (Filed With SEC on May 5, 2015)

[FORM OF PRE-PAID WARRANT] (Filed With SEC on May 5, 2015)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on May 5, 2015)

Units Each Unit consisting of One Share of Common Stock and One Warrant to Purchase One Share of Common Stock per Warrant Cytori Therapeutics, Inc. PLACEMENT AGENCY AGREEMENT (Filed With SEC on May 5, 2015)

Offer Letter dated August 11, 2014, containing compensation terms for Mr. Tiago Girao, VP of Finance and Chief Financial Officer (Filed With SEC on November 7, 2014)

Letter Agreement dated September 19, 2014, by and among the Company, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on November 7, 2014)

Second Amendment to Loan and Security Agreement dated September 29, 2014, by and among the Company, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on November 7, 2014)

Confidential Separation Agreement and General Release of all claims dated October 2, 2014, by and among the Company, and Clyde Shores (Filed With SEC on November 7, 2014)

COMMON STOCKPURCHASE WARRANT CYTORI THERAPEUTICS, INC. (Filed With SEC on October 8, 2014)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on October 8, 2014)

13,500 Units Each Unitconsisting of One Share of Preferred Stock and A Warrant to Purchase up to 1 ###-###-#### Shares of Common Stock Cytori Therapeutics, Inc. PLACEMENT AGENCY... (Filed With SEC on October 8, 2014)

EXHIBIT A AMENDMENT TO WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 8, 2014)

CYTORI THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 8, 2014)

CYTORI THERAPEUTICS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 30, 2014)

SUBSCRIPTION AGREEMENT (Filed With SEC on May 30, 2014)

CONFIDENTIAL (Filed With SEC on May 30, 2014)

AMENDMENT TO WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on May 16, 2014)

CYTORI THERAPEUTICS, INC. $40,000,000 SALESAGREEMENT (Filed With SEC on May 12, 2014)

Amended and Restated License and Supply Agreement dated January 30, 2014 (Filed With SEC on February 4, 2014)

Puregraft Sale-License-Supply Agreement, dated July 30, 2013, by and among the Company and Bimini Technologies LLC (Filed With SEC on November 12, 2013)

Loan and Security Agreement, dated June 28, 2013, by and among the Company, Oxford Finance LLC and Silicon Valley Bank (Filed With SEC on August 9, 2013)

Warrant to Purchase Common Stock issued by the Company on June 28, 2013 in favor of Oxford Finance LLC pursuant to the Loan and Security Agreement dated June 28, 2013 (Filed With SEC on August 9, 2013)

Warrant to Purchase Common Stock issued by the Company on June 28, 2013 in favor of Silicon Valley Bank pursuant to the Loan and Security Agreement dated June 28, 2013 (Filed With SEC on August 9, 2013)

Joint Venture Termination Agreement dated May 8, 2013 by and between the Company and Olympus Corporation (Filed With SEC on May 10, 2013)

7,020,000 Shares of Common Stock par value $0.001 1,053,000 Over-Allotment Shares Cytori Therapeutics, Inc. UNDERWRITING AGREEMENT (Filed With SEC on December 14, 2012)

26-107 (Filed With SEC on October 3, 2012)

First Amendment to Lease Agreement entered into on November 4, 2011, between HCP Callan Rd, LLC. and the Company (Filed With SEC on November 8, 2011)

SECOND AMENDMENT TO AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT (Filed With SEC on September 15, 2011)

SECOND AMENDED AND RESTATED PROMISSORY NOTE (Filed With SEC on September 15, 2011)

PROMISSORY NOTE (Filed With SEC on September 15, 2011)

WARRANT TO PURCHASE 99,668 SHARES OF COMMON STOCK (Filed With SEC on September 15, 2011)

WARRANT TO PURCHASE 9,967 SHARES OF COMMON STOCK (Filed With SEC on September 15, 2011)

WARRANT TO PURCHASE 15,504 SHARES OF COMMON STOCK (Filed With SEC on September 15, 2011)

WARRANT TO PURCHASE 7,752 SHARES OF COMMON STOCK (Filed With SEC on September 15, 2011)

First Amendment to Amended and Restated Loan and Security Agreement, dated June 23, 2011, by and among the Company, Oxford Finance LLC, the other lenders party hereto and General... (Filed With SEC on August 9, 2011)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on July 12, 2011)

CYTORI THERAPEUTICS, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on March 4, 2011)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 9, 2010)

4,000,000 Shares CYTORI THERAPEUTICS, INC. Common Stock ($0.001 par value per Share) UNDERWRITING AGREEMENT (Filed With SEC on October 8, 2010)

COMMONSTOCK PURCHASE AGREEMENT (Filed With SEC on June 22, 2009)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on May 8, 2009)

CYTORITHERAPEUTICS, INC. WARRANTTO PURCHASE COMMON STOCK (Filed With SEC on May 8, 2009)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on May 8, 2009)

CYTORITHERAPEUTICS, INC. WARRANTTO PURCHASE COMMON STOCK (Filed With SEC on March 10, 2009)

SUBSCRIPTIONAGREEMENT (Filed With SEC on March 10, 2009)

4,771,174Shares Warrantsto Purchase6,679,644 Shares CYTORITHERAPEUTICS, INC. CommonStock PLACEMENT AGENCYAGREEMENT (Filed With SEC on March 10, 2009)

LOANAND SECURITY AGREEMENT (Filed With SEC on March 6, 2009)

PROMISSORYNOTE (Filed With SEC on March 6, 2009)

WARRANTTO PURCHASE 89,074 SHARES OF COMMON STOCK Warrant No. CSW-08-022 October 14, 2008 (Filed With SEC on March 6, 2009)

WARRANTTO PURCHASE 89,074 SHARES OF COMMON STOCK Warrant No. CSW-08-023 October 14, 2008 (Filed With SEC on March 6, 2009)

AMENDMENT NO.1 TO COMMON STOCK PURCHASEAGREEMENT (Filed With SEC on August 14, 2008)

AMENDMENTONE TO LICENCE/JOINT DEVELOPMENT AGREEMENT (Filed With SEC on August 11, 2008)

COMMON STOCK PURCHASEAGREEMENT (Filed With SEC on August 8, 2008)

SECURITIESPURCHASE AGREEMENT (Filed With SEC on August 8, 2008)

CYTORITHERAPEUTICS, INC. WARRANTTO PURCHASE COMMON STOCK (Filed With SEC on August 8, 2008)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on August 8, 2008)

AMENDMENTNO. 1 TO MASTERCELL BANKING AND CRYOPRESERVATION AGREEMENT (Filed With SEC on June 10, 2008)

AMENDMENTONE TO LICENCE/COMMERCIAL AGREEMENT (Filed With SEC on March 14, 2008)

AGREEMENT FOR ACCELERATIONAND/OR SEVERANCE (Filed With SEC on March 14, 2008)

AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on February 29, 2008)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on February 19, 2008)

MASTER CELL BANKING AND CRYOPRESERVATION AGREEMENT (Filed With SEC on November 13, 2007)

LICENSE & ROYALTY AGREEMENT (Filed With SEC on November 13, 2007)

GENERAL RELEASE AGREEMENT (Filed With SEC on November 13, 2007)

CYTORI THERAPEUTICS, INC. AMENDMENT NO. 2 TO RIGHTS AGREEMENT (Filed With SEC on September 4, 2007)

ASSET PURCHASE AGREEMENT (Filed With SEC on August 14, 2007)

CONSULTING AGREEMENT (Filed With SEC on August 14, 2007)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on May 11, 2007)

3,745,645 Shares Warrants to Purchase 1,872,823Shares CYTORI THERAPEUTICS, INC. Common Stock PLACEMENT AGENCY AGREEMENT (Filed With SEC on February 26, 2007)

CONFIDENTIAL (Filed With SEC on February 26, 2007)

SUBSCRIPTIONAGREEMENT (Filed With SEC on February 26, 2007)

CYTORITHERAPEUTICS, INC. WARRANT (Filed With SEC on February 26, 2007)

STOCK OPTION EXTENSION AGREEMENT (Filed With SEC on November 14, 2006)

EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2006)

AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT for ADIPOSE-DERIVED STEM CELLS (Filed With SEC on November 14, 2006)

COMMONSTOCK PURCHASE AGREEMENT (Filed With SEC on August 15, 2006)

Formof Common Stock Subscription Agreement (Filed With SEC on August 15, 2006)

1,005,212 Shares CYTORI THERAPEUTICS, INC. Common Stock PLACEMENT AGENCY AGREEMENT (Filed With SEC on August 15, 2006)

STOCK OPTION EXTENSION AGREEMENT (Filed With SEC on August 14, 2006)

PART-TIMEEMPLOYMENT AGREEMENT (Filed With SEC on August 14, 2006)

Agreement for Exclusive Right of Negotiation (Filed With SEC on May 15, 2006)

AIA Document ###-###-####, GeneralConditions of the Contract for Construction, is adopted in this document byreference. This document has been approved and endorsed by the... (Filed With SEC on March 30, 2006)

JOINTVENTURE AGREEMENT (Filed With SEC on March 30, 2006)

LICENSE/COMMERCIAL AGREEMENT (Filed With SEC on March 30, 2006)

LICENSE/ JOINT DEVELOPMENT AGREEMENT (Filed With SEC on March 30, 2006)

SHAREHOLDERSAGREEMENT (Filed With SEC on March 30, 2006)

SEPARATIONAGREEMENT AND GENERAL RELEASE (Filed With SEC on November 14, 2005)

SETTLEMENT AGREEMENT (Filed With SEC on November 14, 2005)

SEVERANCE AGREEMENT AND MUTUAL RELEASE (Filed With SEC on November 14, 2005)

CYTORI THERAPEUTICS, INC. CONSULTING SERVICES AGREEMENT (Filed With SEC on November 14, 2005)

COMMONSTOCK PURCHASE AGREEMENT (Filed With SEC on August 15, 2005)

SUBLEASE AGREEMENT (Filed With SEC on August 15, 2005)

MACROPOREBIOSURGERY, INC. AMENDMENTNO. 1 TO RIGHTS AGREEMENT (Filed With SEC on May 18, 2005)

Salary and Bonuses for Named ExecutiveOfficers (Filed With SEC on May 12, 2005)

DescriptionOf December 8, 2003 Stock Repurchase Transaction With Insiders (Filed With SEC on March 31, 2005)

MACROPOREBIOSURGERY, INC. 1997 STOCK OPTION AND STOCK PURCHASE PLAN NONSTATUTORYSTOCK OPTION AGREEMENT Four Year Vesting - Monthto Month (Filed With SEC on November 15, 2004)

MACROPOREBIOSURGERY, INC. 1997 STOCK OPTION AND STOCK PURCHASE PLAN NONSTATUTORYSTOCK OPTION AGREEMENT Four Year Vesting With One Year Cliff (Filed With SEC on November 15, 2004)

MACROPOREBIOSURGERY, INC. 1997 STOCK OPTIONAND STOCK PURCHASE PLAN INCENTIVE STOCKOPTION AGREEMENT 4 Year Vesting Month to Month (Filed With SEC on November 15, 2004)

MACROPOREBIOSURGERY, INC. 1997 STOCK OPTIONAND STOCK PURCHASE PLAN INCENTIVE STOCKOPTION AGREEMENT Four Year Vestingwith One Year Cliff (Filed With SEC on November 15, 2004)

MacroPoreBiosurgery, Inc. 2004 EquityIncentive Plan of MacroPore Biosurgery, Inc. OPTION EXERCISE AND STOCK PURCHASEAGREEMENT Instructions (Filed With SEC on November 15, 2004)

General terms (Filed With SEC on November 15, 2004)

between MACROPORE BIOSURGERY, INC a Delaware Corporation (MacroPore) and SENKO MEDICAL TRADING CO. a JapaneseCorporation (Senko) (Filed With SEC on November 15, 2004)

2004 Equity Incentive Plan of Macropore Biosurgery, Inc. (Filed With SEC on August 27, 2004)

MUTUAL CONSENT TOTERMINATION OF ASSET PURCHASE AGREEMENT (Filed With SEC on August 16, 2004)

OFFERLETTER FOR THE POSITION OF CHIEF FINANCIAL OFFICER (Filed With SEC on August 16, 2004)

ASSET PURCHASE AGREEMENT (Filed With SEC on May 28, 2004)

CONFIDENTIAL TREATMENT REQUESTED ASSETPURCHASE AGREEMENT*** (Filed With SEC on March 30, 2004)

AMENDMENT (Filed With SEC on November 12, 2003)

LEASE TERMINATION AGREEMENT For the Premises Located at 1125 Business Center Circle, Thousand Oaks, California (Filed With SEC on November 12, 2003)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on November 12, 2003)

CONFIDENTIALTREATMENT REQUESTED EXCLUSIVE LICENSEAGREEMENT for ADIPOSE-DERIVEDSTEM CELLS (Filed With SEC on March 31, 2003)

PLEDGE AGREEMENT (Filed With SEC on March 31, 2003)

SECURED PROMISSORY NOTE $150,000 San Diego, California February 26, 2002 (Filed With SEC on March 31, 2003)

PLEDGEAGREEMENT (Filed With SEC on March 31, 2003)

SECURED PROMISSORYNOTE $328,000 San Diego, California February 26, 2002 (Filed With SEC on March 31, 2003)

MACROPORE, INC. CONSULTING SERVICES AGREEMENT (Filed With SEC on March 31, 2003)

Category

Industry

Companies

Contracts

CYTORI THERAPEUTICS, INC. Contracts & Agreements